Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug
- Posted on July 21, 2026
- By Business News Today
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug
Novo Nordisk has sued Eli Lilly in a U.S. court. The Danish company accuses Lilly of false advertising for its weight-loss medicines. Novo claims Lilly compared lower doses of its drugs with higher doses of Lilly's. Lilly's advertisements allegedly omit newer, higher-dose versions of Novo's medicines. Novo seeks to withdraw these advertisements and seeks damages from Lilly.